Showing results (141-150 of 2,754) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|June 27, 2015
Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimenXin Liu, Zhiyu Chen, Xiaoying Zhao, et al.
Pharmacogenomics|June 20, 2020
Effects of EPHX1 rs2260863 polymorphisms on warfarin maintenance dose in very elderly, frail Han-Chinese populationXianliang Lin, Hao Chen, Le Ni, et al.
Pharmacogenomics|August 20, 2021
Pilot study of multi-gene pharmacogenetic testing for pain management in oncology palliative medicineJai N Patel, Danielle Boselli, James Symanowski, et al.
Pharmacogenomics|August 23, 2021
Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependenceMaggie L McCorkle, David F Kisor, Caroline E Freiermuth, et al.
Pharmacogenomics|May 25, 2021
Inaugural Pharmacogenomics Access and Reimbursement SymposiumSara L Rogers, George P Patrinos, Christina Mitropoulou, et al.
Pharmacogenomics|May 25, 2021
The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescentsKatelyn M Rossow, Samuel E Vaughn, Jeffrey R Strawn, et al.
Pharmacogenomics|May 8, 2015
Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case reportGeoffroy Venton, Julien Colle, Cedric Mercier, et al.
Pharmacogenomics|May 20, 2020
Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapyWenyi Zhao, Jingcheng Wu, Shuqing Chen, et al.
Pharmacogenomics|May 7, 2020
HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI ConsortiumVincent Gagné, Pascal St-Onge, Patrick Beaulieu, et al.
Pharmacogenomics|April 29, 2020
Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?Ana R Pinto, Jani Silva, Ricardo Pinto, et al.
Pageof 276